Les carbapénèmases des entérobactéries

Martinez-Martinez, 2008, Extended-spectrum beta-lactamases and the permeability barrier, Clin Microbiol Infect, 14, 82, 10.1111/j.1469-0691.2007.01860.x Doumith, 2009, Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK, J Antimicrob Chemother, 63, 659, 10.1093/jac/dkp029 Lartigue, 2007, Ertapenem resistance of Escherichia coli, Emerg Infect Dis, 13, 315, 10.3201/eid1302.060747 Lee, 2007, Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss, Int J Antimicrob Agents, 29, 201, 10.1016/j.ijantimicag.2006.09.006 Queenan, 2007, Carbapenemases: the versatile beta-lactamases, Clin Microbiol Rev, 20, 440, 10.1128/CMR.00001-07 Poirel, 2007, Carbapenemases: molecular diversity and clinical consequences, Future Microbiol, 2, 501, 10.2217/17460913.2.5.501 Nordmann, 2009, The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria, Lancet Infect Dis, 9, 228, 10.1016/S1473-3099(09)70054-4 Yigit, 2001, Novel carbapenem-hydrolyzing beta-lactamase KPC-1 from a carbapenem-resistant strain of Klebsiella pneumoniae, Antimicrob Agents Chemother, 45, 1151, 10.1128/AAC.45.4.1151-1161.2001 Naas, 2008, Genetic structures at the origin of acquisition of the beta-lactamase blaKPC gene, Antimicrob Agents Chemother, 52, 1257, 10.1128/AAC.01451-07 Walsh, 2008, Clinically significant carbapenemases: an update, Curr Opin Infect Dis, 21, 367, 10.1097/QCO.0b013e328303670b Lartigue, 2004, First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France, Antimicrob Agents Chemother, 48, 4929, 10.1128/AAC.48.12.4929-4930.2004 Sekiguchi, 2008, KHM-1, a novel plasmid-mediated metallo beta-lactamase from Citrobacter freundii clinical isolate, Antimicrob Agents Chemother, 2008, 4194, 10.1128/AAC.01337-07 Yong, 2009, Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India, Antimicrob Agents Chemother, 53, 5046, 10.1128/AAC.00774-09 Poirel, 2004, Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae, Antimicrob Agents Chemother, 48, 15, 10.1128/AAC.48.1.15-22.2004 Carrër, 2010, Spread of OXA-48-encoding plasmid from Turkey and beyond, Antimicrob Agents Chemother, 54, 1369, 10.1128/AAC.01312-09 Cuzon, 2010, Plasmid-mediated carbapenem-hydrolysing OXA-48 beta-lactamase in Klebsiella pneumoniae from Tunisia, Int J Antimicrob Agents, 36, 91, 10.1016/j.ijantimicag.2010.02.014 Gülmez, 2008, Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss, Int J Antimicrob Agents, 31, 523, 10.1016/j.ijantimicag.2008.01.017 Aktas, 2008, Carbapenem- hydrolyzing oxacillinase OXA-48, persists in Istanbul, Turkey, Chemother, 54, 101, 10.1159/000118661 Poirel, 2004, Chromosome-encoded ambler class D beta-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase, Antimicrob Agents Chemother, 48, 348, 10.1128/AAC.48.1.348-351.2004 Aubron, 2005, Carbapenemase-producing Enterobacteriaceae in US rivers, Emerg Infect Dis, 11, 260, 10.3201/eid1102.030684 Gootz, 2009, Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital, Antimicrob Agents Chemother, 53, 1998, 10.1128/AAC.01355-08 Kitchelk, 2009, Molecular epidemiology of KPC-producing Klebsiella pneumoniae in the United States: clonal expansion of MLST sequence type 258, Antimicrob Agents Chemother, 53, 3365, 10.1128/AAC.00126-09 Leavitt, 2010, Plasmid pKqIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain, J Antimicrob Chemother, 65, 243, 10.1093/jac/dkp417 Navon-Venezia, 2009, First report on hyper-epidemic clone of KPC-3 producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States, Antimicrob Agents Chemother, 53, 818, 10.1128/AAC.00987-08 Pournaras, 2009, Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece, J Antimicrob Chemother, 64, 348, 10.1093/jac/dkp207 Baraniak, 2009, Emergence of Klebsiella pneumoniae ST258 with 1 KPC-2 in Poland, Antimicrob Agents Chemother, 53, 4565, 10.1128/AAC.00436-09 Peirano, 2009, Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil, J Antimicrob Chemother, 63, 265, 10.1093/jac/dkn484 Samuelsen, 2009, Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden, J Antimicrob Chemother, 63, 654, 10.1093/jac/dkp018 Barbier, 2010, Genesis of KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain, Euro Surveill, 15, 10.2807/ese.15.01.19457-en Naas, 2010, Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase, J Antimicrob Chemother, 65, 1305, 10.1093/jac/dkq117 Endimiani, 2009, Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA, J Antimicrob Chemother, 63, 427, 10.1093/jac/dkn547 Carmeli, 2010, Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control, Clin Microbiol Infect, 16, 102, 10.1111/j.1469-0691.2009.03115.x Schwaber, 2008, Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality, Antimicrob Agents Chemother, 52, 1028, 10.1128/AAC.01020-07 Miriagou, 2010, Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues, Clin Microbiol Infect, 16, 112, 10.1111/j.1469-0691.2009.03116.x Rossolini, 2007, Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains, New Microbiol, 30, 332 Souli, 2008, Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe, Euro Surveill, 13, 10.2807/ese.13.47.19045-en Giamarellou, 2009, Multidrug-resistant Gram-negative infections: what are the treatment options?, Drugs, 69, 1879, 10.2165/11315690-000000000-00000 Thomson, 2005, The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!, Curr Opin Microbiol, 8, 518, 10.1016/j.mib.2005.08.014 Falagas, 2007, Risk factors of carbapenem-resistant Klebsiella pneumoniae infections. A matched case control study, J Antimicrob Chemother, 60, 1124, 10.1093/jac/dkm356 Livermore, 2008, NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases, J Antimicrob Chemother, 62, 1053, 10.1093/jac/dkn320 Carrër, 2010, Use of the ChromID extended-spectrum beta-lactamase medium for detecting carbapenemase-producing Enterobacteriaceae, J Clin Microbiol, 48, 1913, 10.1128/JCM.02277-09 Samra, 2008, Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae, J Clin Microbiol, 46, 3110, 10.1128/JCM.00249-08 Schechner, 2009, Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of Enterobacteriaceae family, J Clin Microbiol, 47, 3261, 10.1128/JCM.02368-08 Rodriguez-Martinez, 2010, VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae, Antimicrob Agents Chemother, 54, 471, 10.1128/AAC.00458-09